Medicine guide
Ketek
·
- Prescription status not stated
- Antibiotics, antivirals and antifungals taken into the body
- Active substance
- Telithromycin
- Made by
- Aventis Pharma S.A.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- When prescribing Ketek, consideration should be given to official guidance on the appropriate use ofantibacterial agents and the local prevalence of resistance. Ketek is indicated for the treatment of the following infections: In patients of 18 years and older community-acquired pneumonia, mild or moderate. when treating infections caused by known or suspected beta-lactam- and / or macrolide-resistant strains (according to history of patients or national and / or regional resistance data) covered by the antibacterial spectrum of telithromycin: acute exacerbation of chronic bronchitis; acute sinusitis; In patients of 12 years and older tonsillitis / pharyngitis caused by Streptococcus pyogenes, as an alternative when beta-lactam antibiotics are not appropriate in countries / regions with a significant prevalence of macrolide-resistant S. pyogenes, when mediated by ermTR or mefA.
From the official label · 2026-09-30 · European Medicines Agency
Details
| Made by | Aventis Pharma S.A. |
|---|---|
| Active substance | Telithromycin |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Classification | J01FA15 · Antibiotics, antivirals and antifungals taken into the body |
| Authorised on | 2001-07-09 |
| Last updated by the regulator | 2019-06-19 |
| EMA product number | EMEA/H/C/000354 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.